Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 61,456 followers.

https://t.co/s0m4aProNA

16 Apr 2023

Reply Repost Favourite

https://t.co/s0m4aProNA issued March 23

16 Apr 2023

Reply Repost Favourite

Rituximab therapy can induce immunity to #cancer by activating T cells against EBV specific antigens https://t.co/zFSWjbiu0g

16 Apr 2023

Reply Repost Favourite

Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab https://t.co/6iRFSYoehx

11 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.